216 related articles for article (PubMed ID: 29365311)
1. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
Villa CH; Pan DC; Johnston IH; Greineder CF; Walsh LR; Hood ED; Cines DB; Poncz M; Siegel DL; Muzykantov VR
Blood Adv; 2018 Feb; 2(3):165-176. PubMed ID: 29365311
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte membrane proteins reactive with IgG (warm-reacting) anti-red blood cell autoantibodies: II. Antibodies coprecipitating band 3 and glycophorin A.
Leddy JP; Wilkinson SL; Kissel GE; Passador ST; Falany JL; Rosenfeld SI
Blood; 1994 Jul; 84(2):650-6. PubMed ID: 7517724
[TBL] [Abstract][Full Text] [Related]
3. Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis.
Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Bdeir K; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR
J Pharmacol Exp Ther; 2010 Mar; 332(3):1022-31. PubMed ID: 19952305
[TBL] [Abstract][Full Text] [Related]
4. Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis.
Zaitsev S; Kowalska MA; Neyman M; Carnemolla R; Tliba S; Ding BS; Stonestrom A; Spitzer D; Atkinson JP; Poncz M; Cines DB; Esmon CT; Muzykantov VR
Blood; 2012 May; 119(20):4779-85. PubMed ID: 22493296
[TBL] [Abstract][Full Text] [Related]
5. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.
Carnemolla R; Villa CH; Greineder CF; Zaitsev S; Patel KR; Kowalska MA; Atochin DN; Cines DB; Siegel DL; Esmon CT; Muzykantov VR
FASEB J; 2017 Feb; 31(2):761-770. PubMed ID: 27836986
[TBL] [Abstract][Full Text] [Related]
6. IgG red blood cell autoantibodies in autoimmune hemolytic anemia bind to epitopes on red blood cell membrane band 3 glycoprotein.
Victoria EJ; Pierce SW; Branks MJ; Masouredis SP
J Lab Clin Med; 1990 Jan; 115(1):74-88. PubMed ID: 1688911
[TBL] [Abstract][Full Text] [Related]
7. Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.
Zaitsev S; Spitzer D; Murciano JC; Ding BS; Tliba S; Kowalska MA; Marcos-Contreras OA; Kuo A; Stepanova V; Atkinson JP; Poncz M; Cines DB; Muzykantov VR
Blood; 2010 Jun; 115(25):5241-8. PubMed ID: 20410503
[TBL] [Abstract][Full Text] [Related]
8. ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.
Greineder CF; Johnston IH; Villa CH; Gollomp K; Esmon CT; Cines DB; Poncz M; Muzykantov VR
Blood Adv; 2017 Aug; 1(18):1452-1465. PubMed ID: 29296786
[TBL] [Abstract][Full Text] [Related]
9. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo.
Carnemolla R; Greineder CF; Chacko AM; Patel KR; Ding BS; Zaitsev S; Esmon CT; Muzykantov VR
J Pharmacol Exp Ther; 2013 Nov; 347(2):339-45. PubMed ID: 23965383
[TBL] [Abstract][Full Text] [Related]
10. ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement.
Spitzer D; Unsinger J; Bessler M; Atkinson JP
Mol Immunol; 2004 Feb; 40(13):911-9. PubMed ID: 14725787
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a macaque anti-Rh17-like monoclonal antibody.
Blancher A; Roubinet F; Reid ME; Socha WW; Bailly P; Bénard P
Vox Sang; 1998; 75(1):58-62. PubMed ID: 9745155
[TBL] [Abstract][Full Text] [Related]
12. RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford.
Hipsky CH; Lomas-Francis C; Fuchisawa A; Reid ME; Moulds M; Christensen J; Nickle P; Vege S; Westhoff C
Transfusion; 2011 Jan; 51(1):25-31. PubMed ID: 20609196
[TBL] [Abstract][Full Text] [Related]
13. Molecular and Biocompatibility Characterization of Red Blood Cell Membrane Targeted and Cell-Penetrating-Peptide-Modified Polymeric Nanoparticles.
Sahoo K; Karumuri S; Hikkaduwa Koralege RS; Flynn NH; Hartson S; Liu J; Ramsey JD; Kalkan AK; Pope C; Ranjan A
Mol Pharm; 2017 Jul; 14(7):2224-2235. PubMed ID: 28505457
[TBL] [Abstract][Full Text] [Related]
14. Perturbation of red blood cell membrane rigidity by extracellular ligands.
Paulitschke M; Nash GB; Anstee DJ; Tanner MJ; Gratzer WB
Blood; 1995 Jul; 86(1):342-8. PubMed ID: 7795243
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum anti-band 3 and anti-Gal antibody binding to density-separated human red blood cells.
Sorette MP; Galili U; Clark MR
Blood; 1991 Feb; 77(3):628-36. PubMed ID: 1991171
[TBL] [Abstract][Full Text] [Related]
16. Construction of an anti-IL-1β scfv and TNFRI fusion protein and its therapeutic effect on RA mice model.
Kan F; Ren G; Guo M; Qi J; Zhang Y; Han Y; Zhang Y; Li D
Curr Pharm Biotechnol; 2014; 14(12):1048-61. PubMed ID: 24433504
[TBL] [Abstract][Full Text] [Related]
17. A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
Alam MK; Brabant M; Viswas RS; Barreto K; Fonge H; Ronald Geyer C
BMC Biotechnol; 2018 Sep; 18(1):55. PubMed ID: 30200951
[TBL] [Abstract][Full Text] [Related]
18. Different Involvement of Band 3 in Red Cell Deformability and Osmotic Fragility-A Comparative GP.Mur Erythrocyte Study.
Kuo MS; Chuang CH; Cheng HC; Lin HR; Wang JS; Hsu K
Cells; 2021 Nov; 10(12):. PubMed ID: 34943876
[TBL] [Abstract][Full Text] [Related]
19. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor.
Greineder CF; Chacko AM; Zaytsev S; Zern BJ; Carnemolla R; Hood ED; Han J; Ding BS; Esmon CT; Muzykantov VR
PLoS One; 2013; 8(11):e80110. PubMed ID: 24244621
[TBL] [Abstract][Full Text] [Related]
20. Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo.
Kiseleva RY; Glassman PG; LeForte KM; Walsh LR; Villa CH; Shuvaev VV; Myerson JW; Aprelev PA; Marcos-Contreras OA; Muzykantov VR; Greineder CF
FASEB J; 2020 Sep; 34(9):11577-11593. PubMed ID: 32738178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
